AAAAAA
Results:
1-13
|
Results: 13
Authors:
Gortzak, E
Azzarelli, A
Buesa, J
Bramwell, VHC
van Coevorden, F
van Geel, AN
Ezzat, A
Santoro, A
Oosterhuis, JW
van Glabbeke, M
Kirkpatrick, A
Verweij, J
Citation: E. Gortzak et al., A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma, EUR J CANC, 37(9), 2001, pp. 1096-1103
Authors:
Yamada, I
Matsuo, J
Toyoda, N
Kirkpatrick, A
Citation: I. Yamada et al., Materials processing by gas cluster ion beams, MAT SCI E R, 34(6), 2001, pp. 231-295
Authors:
Kirkpatrick, A
Harris, DC
Johnson, LF
Citation: A. Kirkpatrick et al., Effect of ion implantation on the strength of sapphire at 300-600 degrees C, J MATER SCI, 36(9), 2001, pp. 2195-2201
Authors:
Murdoch, JB
Weeks, JF
Howe, K
Smith, J
Kirkpatrick, A
McCrum, A
Citation: Jb. Murdoch et al., The surgical management of cervical carcinoma within the South West of England: progress through an audit loop, BR J OBST G, 107(3), 2000, pp. 308-315
Authors:
Smith, DB
Oakley, D
Williams, E
Kirkpatrick, A
Citation: Db. Smith et al., Broadcast spray deposits from fan nozzles, APPL ENG AG, 16(2), 2000, pp. 109-113
Authors:
Postmus, PE
Haaxma-Reiche, H
Smit, EF
Groen, HJM
Karnicka, H
Lewinski, T
van Meerbeeck, J
Clerico, M
Gregor, A
Curran, D
Sahmoud, T
Kirkpatrick, A
Giaccone, G
Citation: Pe. Postmus et al., Treatment of brain metastases of small-cell lung cancer: Comparing teniposide and teniposide with whole-brain radiotherapy - A phase III study of theEuropean Organization for the Research and Treatment of Cancer Lung CancerCooperative Group, J CL ONCOL, 18(19), 2000, pp. 3400-3408
Authors:
Beck, K
Chan, VC
Shenoy, N
Kirkpatrick, A
Ramshaw, JAM
Brodsky, B
Citation: K. Beck et al., Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine, P NAS US, 97(8), 2000, pp. 4273-4278
Authors:
Persikov, AV
Ramshaw, JAM
Kirkpatrick, A
Brodsky, B
Citation: Av. Persikov et al., Amino acid propensities for the collagen triple-helix, BIOCHEM, 39(48), 2000, pp. 14960-14967
Authors:
Voute, PA
Souhami, RL
Nooij, M
Somers, R
Cortes-Funes, H
van der Eijken, JW
Pringle, J
Hogendoorn, PCW
Kirkpatrick, A
Uscinska, BM
van Glabbeke, M
Machin, D
Weeden, S
Citation: Pa. Voute et al., A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma, ANN ONCOL, 10(10), 1999, pp. 1211-1218
Authors:
Rivett, DE
Hewish, D
Kirkpatrick, A
Werkmeister, J
Citation: De. Rivett et al., Inhibition of membrane-active peptides by fatty acid-peptide hybrids, J PROTEIN C, 18(3), 1999, pp. 291-295
Authors:
Curtain, C
Separovic, F
Nielsen, K
Craik, D
Zhong, Y
Kirkpatrick, A
Citation: C. Curtain et al., The interactions of the N-terminal fusogenic peptide of HIV-1 gp41 with neutral phospholipids, EUR BIOPHYS, 28(5), 1999, pp. 427-436
Authors:
Shah, NK
Brodsky, B
Kirkpatrick, A
Ramshaw, JAM
Citation: Nk. Shah et al., Structural consequences of D-amino acids in collagen triple-helical peptides, BIOPOLYMERS, 49(4), 1999, pp. 297-302
Authors:
Nielsen, OS
Dombernowsky, P
Mouridsen, H
Crowther, D
Verweij, J
Buesa, J
Steward, W
Daugaard, S
van Glabbeke, M
Kirkpatrick, A
Tursz, T
Citation: Os. Nielsen et al., High-dose epirubicin is not an alternative to standard-dose doxorubicin inthe treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group, BR J CANC, 78(12), 1998, pp. 1634-1639
Risultati:
1-13
|